In Brooklyn, Black and Caribbean LGBTQ+ individuals face some of the highest rates of new HIV infections. But today, protection and empowerment go hand in hand thanks to PrEP (Pre-Exposure Prophylaxis). Backed by the CDC, New York State Department of Health, Gilead, and STARprogram.nyc, PrEP offers a powerful layer of protection that lets you stay in control of your health, your relationships, and your future. The Disparity is Real: HIV continues to disproportionately affect

A groundbreaking step in HIV prevention has arrived. The U.S. Food and Drug Administration (FDA) has approved Yeztugo® (lenacapavir) — the first and only long-acting injectable PrEP administered twice a year — for use in adults and adolescents weighing at least 35kg (77 lbs). Backed by clinical success and designed for convenience, this innovative option is changing how we approach HIV prevention. What Is Yeztugo® (lenacapavir)? Yeztugo® is a twice-a-year injectable form of p